# Feasiblity and Safety of Home-based Intensive Chemotherapy

> **NCT04904211** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 104 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **OTHER:** Home-based chemotherapy

## Key facts

- **NCT ID:** NCT04904211
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2021-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904211, "Feasiblity and Safety of Home-based Intensive Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04904211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*